BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 30130664)

  • 1. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.
    Valle S; Martin-Hijano L; Alcalá S; Alonso-Nocelo M; Sainz B
    Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29373514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
    Rausch V; Liu L; Apel A; Rettig T; Gladkich J; Labsch S; Kallifatidis G; Kaczorowski A; Groth A; Gross W; Gebhard MM; Schemmer P; Werner J; Salnikov AV; Zentgraf H; Büchler MW; Herr I
    J Pathol; 2012 Jul; 227(3):325-35. PubMed ID: 22262369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
    Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
    Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
    Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
    Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
    Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells.
    Valle S; Alcalá S; Martin-Hijano L; Cabezas-Sáinz P; Navarro D; Muñoz ER; Yuste L; Tiwary K; Walter K; Ruiz-Cañas L; Alonso-Nocelo M; Rubiolo JA; González-Arnay E; Heeschen C; Garcia-Bermejo L; Hermann PC; Sánchez L; Sancho P; Fernández-Moreno MÁ; Sainz B
    Nat Commun; 2020 Oct; 11(1):5265. PubMed ID: 33067432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ever-changing landscape of pancreatic cancer stem cells.
    Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B
    Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
    Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
    Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
    Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
    Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma.
    Palma AM; Bushnell GG; Wicha MS; Gogna R
    Adv Cancer Res; 2023; 159():343-372. PubMed ID: 37268400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes.
    Ai J; Wörmann SM; Görgülü K; Vallespinos M; Zagorac S; Alcala S; Wu N; Kabacaoglu D; Berninger A; Navarro D; Kaya-Aksoy E; Ruess DA; Ciecielski KJ; Kowalska M; Demir IE; Ceyhan GO; Heid I; Braren R; Riemann M; Schreiner S; Hofmann S; Kutschke M; Jastroch M; Slotta-Huspenina J; Muckenhuber A; Schlitter AM; Schmid RM; Steiger K; Diakopoulos KN; Lesina M; Sainz B; Algül H
    Gastroenterology; 2021 Jul; 161(1):318-332.e9. PubMed ID: 33819482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
    Ogunleye AO; Nimmakayala RK; Batra SK; Ponnusamy MP
    Stem Cells; 2023 May; 41(5):417-430. PubMed ID: 36869789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
    Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
    J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
    Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
    Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity and targeting of pancreatic cancer stem cells.
    Penchev VR; Rasheed ZA; Maitra A; Matsui W
    Clin Cancer Res; 2012 Aug; 18(16):4277-84. PubMed ID: 22896694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
    Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
    Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome.
    Biondani G; Zeeberg K; Greco MR; Cannone S; Dando I; Dalla Pozza E; Mastrodonato M; Forciniti S; Casavola V; Palmieri M; Reshkin SJ; Cardone RA
    FEBS J; 2018 Jun; 285(11):2104-2124. PubMed ID: 29660229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and epigenetics of pancreatic cancer stem cells.
    Perusina Lanfranca M; Thompson JK; Bednar F; Halbrook C; Lyssiotis C; Levi B; Frankel TL
    Semin Cancer Biol; 2019 Aug; 57():19-26. PubMed ID: 30273655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.